AbGenomics B.V Taiwan Branch

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, AbGenomics B.V Taiwan Branch sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).

6 total trials none currently recruiting 4 completed early-phase tilt upper quartile by trial count

AbGenomics B.V Taiwan Branch: 6 sponsored US clinical trials, none currently recruiting.

AbGenomics B.V Taiwan Branch sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 0 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Moderate-to-severe Chronic Plaque Psoriasis, with 1 trials.

Upper-quartile sponsor footprint

AbGenomics B.V Taiwan Branch sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

6 total, page 1 of 1

TERMINATED Phase 1

A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer

NCT02908451
TERMINATED Phase 1

A Study of AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant

NCT02436460
COMPLETED Phase 2

A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis

NCT02267642
COMPLETED Phase 2

A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT02223039
COMPLETED Phase 2

Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients

NCT01855880
COMPLETED Phase 1

An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors

NCT01466569

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 3

Therapeutic Areas

Moderate-to-severe Chronic Plaque Psoriasis 1
Psoriatic Arthritis 1

How the AbGenomics B.V Taiwan Branch early-phase archive is shaped

6 indexed studies, none listed as recruiting (0% open); 4 completed (67%).

Phase mix: 0 late (III/IV) vs 6 early (I/II) (early-phase heavy).

Top condition: Moderate-to-severe Chronic Plaque Psoriasis (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

AbGenomics B.V Taiwan Branch: archived-pipeline peers nationwide

Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

AbGenomics B.V Taiwan Branch sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60%80% Total trials Recruiting share AbGenomics B.V Taiwan Branch23andMeAardvark TherapeuticsAbbisko Therapeutics CoAbivax S.A.10xBio22nd Century Group3-C Institute for Social Development3 Waves Wellness
AbGenomics B.V Taiwan Branch sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

AbGenomics B.V Taiwan Branch sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 6 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this AbGenomics B.V Taiwan Branch page

6 registered trials is a research-attention snapshot, not an endorsement of AbGenomics B.V Taiwan Branch or any single study.

  • None of AbGenomics B.V Taiwan Branch's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Moderate-to-severe Chronic Plaque Psoriasis is the condition AbGenomics B.V Taiwan Branch studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Moderate-to-severe Chronic Plaque Psoriasis trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. AbGenomics B.V Taiwan Branch pipeline card: 6 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.